© 2010 John Wiley & Sons A/S
Acta Neuropsychiatrica 2010: 22: 81–86 All rights reserved DOI: 10.1111/j.1601-5215.2010.00457.x
ACTA NEUROPSYCHIATRICA
Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders Issler CK, Monkul ES, Amaral JAMS, Tamada RS, Shavitt RG, Miguel EC, Lafer B. Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders. Objective: Although bipolar disorder (BD) with comorbid obsessive-compulsive disorder (OCD) is highly prevalent, few controlled studies have assessed this comorbidity. The objective of this study was to investigate the clinical characteristics and expression of comorbid disorders in female BD patients with OCD. Method: We assessed clinically stable female outpatients with BD: 15 with comorbid OCD (BD+OCD group) and 15 without (BD/no-OCD group). All were submitted to the Structured Clinical Interview for DSM-IV, with additional modules for the diagnosis of kleptomania, trichotillomania, pathological gambling, onychophagia and skin picking. Results: The BD+OCD patients presented more chronic episodes, residual symptoms and previous depressive episodes than the BD/no-OCD patients. Of the BD+OCD patients, 86% had a history of treatment-emergent mania, compared with only 40% of the BD/no-OCD patients. The following were more prevalent in the BD+OCD patients than the BD/no-OCD patients: any anxiety disorder other than OCD; impulse control disorders; eating disorders; and tic disorders. Conclusion: Female BD patients with OCD may represent a more severe form of disorder than those without OCD, having more depressive episodes and residual symptoms, and being at a higher risk for treatment-emergent mania, as well as presenting a greater anxiety and impulse control disorder burden.
Introduction
Recent research shows a strong connection between bipolar disorder (BD) and obsessive-compulsive disorder (OCD), a link that is potentially stronger than that established between OCD and major depression (1–3). A reanalysis of the Epidemiological Catchment Area Study data set showed that lifetime rates of OCD in patients with BD and major depression were 21 and 12.2%, respectively, and that BD patients were 1.7 times more likely to have OCD than were patients with major depression (1). As Angst
¨ Cilly Kluger Issler1 , Emel Serap 1 Monkul , Jose´ Antonio de Mello Siqueira Amaral1 , Renata Sayuri Tamada1 , Roseli Gedanke Shavitt2 , Eur´ıpedes C. Miguel2 , Beny Lafer1 1 Bipolar
Disorder Research Program, Department of Psychiatry, University of S˜ao Paulo School of Medicine, S˜ao Paulo, Brazil; and 2 Obsessive-Compulsive Disorder Research Program, Department of Psychiatry, University of S˜ao Paulo School of Medicine, S˜ao Paulo, Brazil
Keywords: obsessive-compulsive disorder; bipolar disorder; comorbidity; impulse control disorders Dr Beny Lafer, PROMAN – Programa de Transtorno Bipolar, R. Dr. Ov´ıdio Pires de Campos, 785 – 3◦ andar – Ala Sul Sala 04, Cerqueira Cesar – CEP 05403-010, S˜ao Paulo / SP / Brasil. Tel/Fax: +55 (11) 30697928; E-mail: [email protected]
and colleagues (2) pointed out, a National Comorbidity Survey replication study also found lifetime OCD to be more prevalent in patients with BD (OR = 9.0) than in those with major depression (OR = 3.4). In clinical settings, patients with BD are reported to have 5.1-fold greater chance of having OCD than do patients with major depression (3). Similarly, Grabe and colleagues (4) reported in a group of female patients with OCD that the odds ratio for the risk of comorbid BD was 30, compared with 5.3 for the risk of comorbid major depression. Finally, a recent prospective cohort study, using a broad definition of 81
Issler et al. bipolar II disorder (having had a major depressive episode plus hypomania or hypomanic symptoms), showed significant OCD-BD comorbidity, whereas there was no clear association between OCD and major depression (2). Although OCD-BD comorbidity is now considered highly prevalent, very few controlled studies have examined the impact of comorbid OCD on the course and treatment of BD. Kr¨uger and colleagues (5) examined 143 subjects with BD I and II, and found a current OCD diagnosis only in male BD II patients (n = 10). The authors reported that these patients, in comparison with BD patients without OCD, presented fewer previous affective episodes but a higher incidence of prior suicide attempts, although there was no significant difference between the two groups in terms of substance abuse, comorbidity with other anxiety disorders, somatization disorder or binge eating. Another study, in which follow-up assessments of functional status were carried out in patients with BD I and OCD (64% male) for 1.5–7.5 years after discharge, showed the suicide attempt rates to be no higher among those patients than among patients with BD only or OCD only (6). However, as expected, patients with OCDBD comorbidity were rehospitalised 2.9 times more frequently than those with OCD only. In this study, we investigated the clinical characteristics and the expression of comorbid disorders in female BD patients with OCD, comparing the findings with those we obtained for female BD patients without OCD. We used standard clinical instruments to evaluate the course of BD, together with semistructured interviews encompassing other lifetime Diagnostic and Statistical Manual, Fourth Edition (DSM-IV ) psychiatric diagnoses, such as anxiety and impulse control disorders. To the best of our knowledge, this is the first study assessing impulse control disorders in OCD-BD comorbidity. Material and methods Sample
The study sample consisted of 30 clinically stable female outpatients with BD (25 with BP-I and 5 with BP-II), divided into two groups: BD+OCD, consisting of 15 patients (12 with BP-I and 3 with BP-II) with comorbid OCD; and BD/no-OCD, consisting of 15 patients (13 with BP-I and 2 with BP-II) without OCD. The groups were matched for age, ethnicity, education and socioeconomic status. Patients were recruited consecutively from among those seeking treatment at the outpatient units of the Institute of Psychiatry of the University of S˜ao Paulo School of Medicine. All assessments were made by the first author. Because only 3 of the first 15 82
patients enrolled were male, the decision was made to exclude males and thereby select a more homogeneous sample. Of the 15 patients in the BD+OCD group, 12 had sought treatment for BD symptoms, and 3 had sought treatment for OCD symptoms. However, careful diagnostic evaluation revealed BD to be the primary diagnosis in those three patients as well. A detailed analysis of the clinical characteristics of OCD in these patients is published elsewhere (7). The inclusion criterion was having been diagnosed with BP-I or BP-II, with and without comorbid OCD, as determined using the Structured Clinical Interview for DSM-IV Disorders – patient version (SCID/P) (8). Patients presenting concurrent organic brain disease or schizoaffective disorder were excluded. The Institutional Review Board of the University of Sao Paulo approved this study, and, after having been given a complete description of the study, all participants gave written informed consent. Materials
Diagnostic assessments were conducted using the SCID/P (8). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was administered to assess the severity of obsessive-compulsive symptoms (9). For the diagnosis of kleptomania, trichotillomania, pathological gambling, onychophagia and skin picking, specific modules were administered (10). Chronic motor and vocal tics were assessed using the Yale Global Tic Severity Scale (11). The specific module of the Kiddie Schedule for Affective Disorders and Schizophrenia, epidemiological edition (12) was applied to identify attention deficit hyperactivity disorder. Clinical information was obtained through the use of a retrospective mood chart (13), together with data from psychiatric interviews and medical records. Patients requiring antidepressant medication for at least 3 days per week in the 2 weeks preceding a manic episode, as defined by Stoll and colleagues (14), were considered to have treatmentemergent manic symptoms. Age at onset of BD was defined as the age at which the patient first met the DSM-IV criteria for a major mood episode, and age at onset of OCD was defined as the age at which the first obsessive or compulsive symptoms appeared. In accordance with the criteria adopted by Ros´arioCampos and colleagues (15), onset of OCD before the age of 10 years was classified as early-onset OCD. An episode was considered to be chronic if all criteria for a major mood episode were met continuously for at least 2 years. When symptoms of an episode continued, but all criteria for BD were no longer met, the patient was classified as having residual symptoms.
Bipolar disorder and obsessive-compulsive disorder Statistical analysis
All statistical analyses were conducted using the Statistical Package for the Social Sciences, version 14 (SPSS Inc., Chicago, IL), and two-tailed tests. The level of statistical significance was set at p < .05. We used a chi-squared test for categorical variables and the Student’s t-test for continuous variables. All of the continuous variables showed normal distribution. Results Sociodemographic data
There was no significant difference between the two groups in terms of marital status or employment (p > .05 for both). The proportions of single patients, patients who were married/living with a steady partner and divorced/separated patients were 40, 40 and 20%, respectively, for the BD+OCD group, compared with 26.7, 26.7 and 46.7%, respectively, for the BD/no-OCD group. In the BD+OCD group, 13% of the patients were unemployed, as were 26.7% of those in the BD/no-OCD group, although the difference between the two groups did not reach statistical significance for this variable. Clinical characteristics
Clinical characteristics of both patient groups are shown in Table 1. Mean Yale-Brown ObsessiveCompulsive Scale (Y-BOCS) score in the BD+OCD group was 26.1 ± 6.9. All patients in the BD+OCD group and 13 patients in the BD/no-OCD group were receiving drug treatment. There were 28 patients using mood stabilizers (15 in the BD+OCD group; 13 in the BD/no-OCD group), 14 using antipsychotics (9 in the BD+OCD group; 5 in the
BD/no-OCD group) and 12 using antidepressants (8 in the BD+OCD group; 4 in the BD/no-OCD group). The age at onset of BD was numerically lower in the BD+OCD group, although the difference between the two groups did not reach statistical significance. Of the 15 patients in the BD+OCD group, 9 (60%) had early-onset OCD (age at onset, .05). Excluding OCD, the number of Axis I comorbidities per patient was significantly higher in the BD+OCD group than the BD/no-OCD group (p = .009), with all the patients in this group having one or more comorbidity. This difference remained significant after the exclusion of tic disorders and impulse control disorders (p = .05). More than 95% of the patients in the BD+OCD group had at least two comorbidities other than OCD (Table 4). Discussion
In comparison with those in the BD/no-OCD group, the patients in the BD+OCD group had a greater number of previous depressive episodes, chronic episodes and residual symptoms, as well as higher rates of treatment-emergent affective switch. In addition, patients in the BD+OCD group had more coexisting psychiatric disorders, 93.3% having another anxiety disorder and 60% having impulse control disorders. Taken together, these findings suggest that, in comparison with their non-OCD counterparts, bipolar patients with OCD comorbidity suffer from a more severe form of disorder, as also suggested by Hantouche and colleagues (16). The emergence of antidepressant-associated mania has been previously documented in patients with OCD (17,18). In addition, Perugi and colleagues (17) showed that patients with BD and OCD have a greater number of concurrent major depressive episodes and treatment-emergent affective switches than do OCD patients without comorbid BD. Despite the early appearance of OCD symptoms, most of our patients sought treatment for BD symptoms, highlighting the importance of inquiring about obsessions and compulsions when evaluating BD patients, as recommended by Chen and Dilsaver (1). The inverse is also true for patients with OCD, because three patients in this cohort sought treatment for obsessivecompulsive symptoms and were unaware of having BD. In addition to the mood stabilizer resistance previously documented (19), comorbid OCD can render patients with BD more prone to treatmentemergent mania. 84
In our sample, the age at onset of BD did not differ between the two groups, despite the fact that the age at onset of BD was numerically lower in the BD+OCD group. Also, in our BD+OCD group, we found the onset of OCD to be much earlier than that of BD. This is in accordance with the findings of two previous studies (16,20) showing that the manifestation of obsessive-compulsive symptoms occurs early (before age 16) in OCD patients with comorbid BDs. Chen and Dilsaver (1) hypothesised that concurrence and same age at onset of BD and OCD can be interpreted as these two disorders having the same underlying diathesis. In our study, age at onset of BD was defined as the age at which the patient first met the DSM-IV criteria for a major mood episode, whereas age at onset of OCD was defined as the age at which the first obsessive or compulsive symptoms appeared. OCD research provides evidence for the existence of an early-onset subtype distinct from the other forms of the disorder, and our data also suggest that BD is associated with the early-onset OCD subtype (21,22). Although further studies are needed to confirm this finding, it might have some etiologic implications, as suggested by Chen and Dilsaver (1,21,22). Although 40% of the patients in our BD+OCD group reported one or more prior suicide attempts, this was not significantly different from the BD/noOCD group (33.3%). This is in accordance with Centorrino and colleagues’ finding of no significant differences in suicide attempts between BD patients with comorbid OCD and those with BD only (6). However, in this study, this result may reflect a possible type II error because of the small size of our sample. In contrast, Kr¨uger and colleagues (5) reported a higher incidence of prior suicide attempts in a group of male BD type II patients with OCD (n = 10) compared to BD patients without OCD, and all of the patients evaluated had been diagnosed with comorbid dysthymia, a condition that might explain the elevated suicide attempt rates. Chen and Dilsaver (1) also reported elevated suicidality in patients with OCD-BD comorbidity, although they explained this as being a function of the higher number of patients with comorbid panic disorder in their sample. Suicide attempt rates in OCD patients have been reported to be around 10–27% (23,24), and anxiety disorders are known independent risk factors for suicide attempts (25,26). Therefore, the elevated suicide rates observed in the BD+OCD patients may be attributable to OCD and other concurrent anxiety disorders. In this study, 93% of the patients in the BD+OCD group had another comorbid anxiety disorder; panic disorder, specific phobias and social phobia being the most prevalent. Chen and Dilsaver (1) reported
Bipolar disorder and obsessive-compulsive disorder a similar finding: increased rates of comorbid panic disorder in subjects with OCD-BD comorbidity. Masi and colleagues (20) found that the rate of panic disorder was higher among youths with OCD-BD comorbidity than among those with BD and no OCD. Finally, Dilsaver and colleagues (3) examined the question of ‘cumulative anxiety disorder comorbidity’ in juvenile patients with OCD-BD comorbidity and found that comorbid OCD resulted in a 10-fold increase in the odds of having panic disorder, whereas having OCD and panic disorder was associated with social phobia. Our finding of the cumulative presence of anxiety disorders in the BD+OCD group also supports the notion that the presence of one comorbid anxiety disorder can increase the chances of having another, as suggested by Dilsaver and colleagues (3). To the best of our knowledge, this is the first study to use specific modules to investigate impulse control disorders in BD patients with OCD. Of the 15 patients in the BD+OCD group, 9 (60%) had an impulse control disorder, compared with only 2 (13%) of those in the BD/no-OCD group. Although it is well established that anxiety and impulsivity are common characteristics of BD, the interplay between the two in BD is a topic that has rarely been investigated. One recent study (27) showed that BD patients with a comorbid anxiety disorder displayed significantly higher levels of impulsivity (as assessed using the Barratt Impulsiveness Scale) than did those without an anxiety disorder. Hantouche and colleagues (16) stated that a higher prevalence of concurrent disorders (panic disorder, phobias, anger attacks, impulsive disorders and eating disorders) is presumptive of bipolar OCD. However, the DSM-IV impulse control disorders comprise heterogeneous disorders, including different subgroups with some common features among them. For instance, skin picking, onychophagia and trichotillomania, along with tic disorders and body dysmorphic disorder, are now conceptualised as obsessive-compulsive spectrum disorders, based on common psychopathological features and genetic background (21,28). Such disorders were more common in the BD+OCD group in our sample; however, based on the ‘obsessivecompulsive spectrum disorders’ conceptualisation, one might also argue that it is expected to see more of these disorders in any population of patients with OCD. Additional research is needed to examine the complex interplay between impulse controls disorders, OCD and BD. By including only female patients, we were able to control for possible confounding factors related to gender. However, the small sample size constitutes a significant limitation of our study. Although the
exclusion of males made our sample more homogeneous, it also reduced the external validity of our findings. Therefore, future studies on this theme should include larger patient samples, composed of both genders, to validate the findings described here. A major strength of this work is that our data were collected using structured interviews and wellestablished assessment scales. Our findings complement and enhance those of previous studies, showing that OCD-BD comorbidity is linked with greater illness severity. Patients with OCD-BD comorbidity present a higher number of depressive episodes, have more residual symptoms and are at a greater risk of treatment-emergent mania. These findings could have significant clinical implications. For instance, in view of research favouring atypical antipsychotic augmentation for OCD that is refractory to selective serotonin uptake inhibitors (29,30), the choice of atypical antipsychotics should be considered in patients with OCD-BD comorbidity, because it might help prevent antidepressant-associated manic switch (16,31) and could improve the symptoms related to both disorders. Clinicians should also be aware of the higher rates of anxiety disorders and impulse control disorders commonly seen in this subgroup of patients and should establish comprehensive therapeutic strategies for treating these patients. Finally, although the data available are insufficient to allow us to define OCD-BD comorbidity as a distinct entity, future research examining the familial-genetic and neurobiological aspects of this comorbidity will further the understanding of its exact nature. Acknowledgements This research was supported in part by a generous donation from the Thompson Motta Family. Dr Lafer has received speaker’s honoraria from AstraZeneca in 2007. Dr Monkul is an employee of Eli Lilly Brazil. Address of the department to which the work should be attributed is Department of Psychiatry, University of S˜ao Paulo School of Medicine, S˜ao Paulo, Brazil. The authors do not have any affiliation with or financial interest in any organisation that might pose a conflict of interest.
References 1. Chen YW, Dilsaver SC. Comorbidity for obsessivecompulsive disorder in bipolar and unipolar disorders. Psychiatry Res 1995;59:57–64. 2. Angst J, Gamma A, Endrass J et al. Obsessivecompulsive syndromes and disorders: significance of comorbidity with bipolar disorder and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci 2005;255:65–71. 3. Dilsaver SC, Akiskal HS, Akiskal KK, Benazzi F. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality. J Affect Disord 2006;96:249–258.
85
Issler et al. 4. Grabe HJ, Meyer C, Hapke U et al. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessivecompulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci 2001;251:130–135. ¨ 5. Kruger S, Braunig P, Cooke RG. Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord 2000;2:71–74. 6. Centorrino F, Hennen J, Mallya G, Egli S, Clark T, Baldessarini RJ. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both. Hum Psychopharmacol Clin Exp 2006;21:189–193. 7. Issler CK, Amaral JAMS, Tamada RS et al. Clinical expression of obsessive-compulsive disorder in women with bipolar disorder. Rev Bras Psiquiatr 2005;27:139–142. 8. First MB, Spitzer RL, Gibson M et al. Structured clinical interview for DSM-IV Axis I disorders – patient edition (version 2.0, 8/98 revision). New York, Biometrics Research Department; 1997. 9. Goodman WK, Price LH, Rasmussen SA et al. The YaleBrown Obsessive Compulsive Scale: development, use and reliability. Arch Gen Psychiatry 1989;46:1006–1011. 10. First MB. Structured clinical interview for DSM-IV-TR Impulse Control Disorders Not Elsewhere Classified (SCIDTCIm). Biometrics Research Department; New York State Psychiatric Institute; September 2004. 11. Leckman JF, Riddle MA, Hardin MT et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566–573. 12. Orvaschel H, Pu˙Ig-Ant˙Ich J. Kiddie-SADS-E: Schedule for affective disorder and Schizophrenia for school-age children – epidemiologic version (4th version). Ft. Lauderdale, Fl. Nova University, Center for Psychological Study; 1987. 13. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996;(2 Suppl. 1):32S–47S. 14. Stoll AL, Mayer PV, Kolbrener M et al. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994;151: 1642–1645. 15. Rosar˙Io-Campos MC, Leckman JF, Mercadante MT et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry 2001;158:1899–1903. 16. Hantouche EG, Angst J, Demonfaucon C, Perugi G, Lancrenon S, Akiskal HS. Cyclothymic OCD: a distinct form? J Affect Disord 2003;75:1–10. 17. Perug˙I G, Ton˙I C, Frare F, Trav˙Ierso MC, Hantouche MC, Ak˙Iskal HS. Obsessive-compulsive-bipolar comorbid-
86
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
ity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry 2002;63:1129–1134. Berk M, Koopowitz LE, Szabo CP. Antidepressantinduced mania in OCD. Eur Neuropsychopharmacol 1996; 6:9–11. Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen G. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004;65:1106–1113. Mas˙I G, Perug˙I G, Ton˙I C et al. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord 2004;78:175–183. M˙Iguel EC, Leckman JF, Rauch S et al. Obsessivecompulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005;10:258–275. ´ de Mathis MA, Diniz JB, do Rosario MC et al. What is the optimal way to subdivide obsessive-compulsive disorder? CNS Spectr 2006;11:762–768, 771–774, 776–779. Torres AR, de Abreu Ramos-Cerqueira AT, Torresan RC, de Souza Dom˙Ingues M, Hercos AC, ˜ AB. Prevalence and associated factors for suiciGu˙Imaraes dal ideation and behaviors in obsessive-compulsive disorder. CNS Spectr 2007;12:771–778. Kamath P, Reddy YC, Kandavel T. Suicidal behavior in obsessive-compulsive disorder. J Clin Psychiatry 2007;68:1741–1750. Norton PJ, Temple SR, Pett˙It JW. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression? J Behav Ther Exp Psychiatry 2008;39:515–525. Bolton JM, Cox BJ, Af˙If˙I TO, Enns MW, B˙Ienvenu OJ, Sareen J. Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow-up study. Depress Anxiety 2008;25:477–481. Taylor CT, H˙Irshfeld-Becker DR, Ostacher MJ et al. Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord 2008;22:868–876. B˙Ienvenu OJ, Samuels JF, R˙Iddle MA et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000;48:287–293. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995;56:423–429. Koran LM, Ringold AL, Elliott MA. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2000;61:514–517. Raja M, Azzon˙I A. Clinical management of obsessivecompulsive-bipolar comorbidity: a case series. Bipolar Disord 2004;6:264–270.
Acta Neuropsychiatrica 2010: 22: 81–86 All rights reserved DOI: 10.1111/j.1601-5215.2010.00457.x
ACTA NEUROPSYCHIATRICA
Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders Issler CK, Monkul ES, Amaral JAMS, Tamada RS, Shavitt RG, Miguel EC, Lafer B. Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders. Objective: Although bipolar disorder (BD) with comorbid obsessive-compulsive disorder (OCD) is highly prevalent, few controlled studies have assessed this comorbidity. The objective of this study was to investigate the clinical characteristics and expression of comorbid disorders in female BD patients with OCD. Method: We assessed clinically stable female outpatients with BD: 15 with comorbid OCD (BD+OCD group) and 15 without (BD/no-OCD group). All were submitted to the Structured Clinical Interview for DSM-IV, with additional modules for the diagnosis of kleptomania, trichotillomania, pathological gambling, onychophagia and skin picking. Results: The BD+OCD patients presented more chronic episodes, residual symptoms and previous depressive episodes than the BD/no-OCD patients. Of the BD+OCD patients, 86% had a history of treatment-emergent mania, compared with only 40% of the BD/no-OCD patients. The following were more prevalent in the BD+OCD patients than the BD/no-OCD patients: any anxiety disorder other than OCD; impulse control disorders; eating disorders; and tic disorders. Conclusion: Female BD patients with OCD may represent a more severe form of disorder than those without OCD, having more depressive episodes and residual symptoms, and being at a higher risk for treatment-emergent mania, as well as presenting a greater anxiety and impulse control disorder burden.
Introduction
Recent research shows a strong connection between bipolar disorder (BD) and obsessive-compulsive disorder (OCD), a link that is potentially stronger than that established between OCD and major depression (1–3). A reanalysis of the Epidemiological Catchment Area Study data set showed that lifetime rates of OCD in patients with BD and major depression were 21 and 12.2%, respectively, and that BD patients were 1.7 times more likely to have OCD than were patients with major depression (1). As Angst
¨ Cilly Kluger Issler1 , Emel Serap 1 Monkul , Jose´ Antonio de Mello Siqueira Amaral1 , Renata Sayuri Tamada1 , Roseli Gedanke Shavitt2 , Eur´ıpedes C. Miguel2 , Beny Lafer1 1 Bipolar
Disorder Research Program, Department of Psychiatry, University of S˜ao Paulo School of Medicine, S˜ao Paulo, Brazil; and 2 Obsessive-Compulsive Disorder Research Program, Department of Psychiatry, University of S˜ao Paulo School of Medicine, S˜ao Paulo, Brazil
Keywords: obsessive-compulsive disorder; bipolar disorder; comorbidity; impulse control disorders Dr Beny Lafer, PROMAN – Programa de Transtorno Bipolar, R. Dr. Ov´ıdio Pires de Campos, 785 – 3◦ andar – Ala Sul Sala 04, Cerqueira Cesar – CEP 05403-010, S˜ao Paulo / SP / Brasil. Tel/Fax: +55 (11) 30697928; E-mail: [email protected]
and colleagues (2) pointed out, a National Comorbidity Survey replication study also found lifetime OCD to be more prevalent in patients with BD (OR = 9.0) than in those with major depression (OR = 3.4). In clinical settings, patients with BD are reported to have 5.1-fold greater chance of having OCD than do patients with major depression (3). Similarly, Grabe and colleagues (4) reported in a group of female patients with OCD that the odds ratio for the risk of comorbid BD was 30, compared with 5.3 for the risk of comorbid major depression. Finally, a recent prospective cohort study, using a broad definition of 81
Issler et al. bipolar II disorder (having had a major depressive episode plus hypomania or hypomanic symptoms), showed significant OCD-BD comorbidity, whereas there was no clear association between OCD and major depression (2). Although OCD-BD comorbidity is now considered highly prevalent, very few controlled studies have examined the impact of comorbid OCD on the course and treatment of BD. Kr¨uger and colleagues (5) examined 143 subjects with BD I and II, and found a current OCD diagnosis only in male BD II patients (n = 10). The authors reported that these patients, in comparison with BD patients without OCD, presented fewer previous affective episodes but a higher incidence of prior suicide attempts, although there was no significant difference between the two groups in terms of substance abuse, comorbidity with other anxiety disorders, somatization disorder or binge eating. Another study, in which follow-up assessments of functional status were carried out in patients with BD I and OCD (64% male) for 1.5–7.5 years after discharge, showed the suicide attempt rates to be no higher among those patients than among patients with BD only or OCD only (6). However, as expected, patients with OCDBD comorbidity were rehospitalised 2.9 times more frequently than those with OCD only. In this study, we investigated the clinical characteristics and the expression of comorbid disorders in female BD patients with OCD, comparing the findings with those we obtained for female BD patients without OCD. We used standard clinical instruments to evaluate the course of BD, together with semistructured interviews encompassing other lifetime Diagnostic and Statistical Manual, Fourth Edition (DSM-IV ) psychiatric diagnoses, such as anxiety and impulse control disorders. To the best of our knowledge, this is the first study assessing impulse control disorders in OCD-BD comorbidity. Material and methods Sample
The study sample consisted of 30 clinically stable female outpatients with BD (25 with BP-I and 5 with BP-II), divided into two groups: BD+OCD, consisting of 15 patients (12 with BP-I and 3 with BP-II) with comorbid OCD; and BD/no-OCD, consisting of 15 patients (13 with BP-I and 2 with BP-II) without OCD. The groups were matched for age, ethnicity, education and socioeconomic status. Patients were recruited consecutively from among those seeking treatment at the outpatient units of the Institute of Psychiatry of the University of S˜ao Paulo School of Medicine. All assessments were made by the first author. Because only 3 of the first 15 82
patients enrolled were male, the decision was made to exclude males and thereby select a more homogeneous sample. Of the 15 patients in the BD+OCD group, 12 had sought treatment for BD symptoms, and 3 had sought treatment for OCD symptoms. However, careful diagnostic evaluation revealed BD to be the primary diagnosis in those three patients as well. A detailed analysis of the clinical characteristics of OCD in these patients is published elsewhere (7). The inclusion criterion was having been diagnosed with BP-I or BP-II, with and without comorbid OCD, as determined using the Structured Clinical Interview for DSM-IV Disorders – patient version (SCID/P) (8). Patients presenting concurrent organic brain disease or schizoaffective disorder were excluded. The Institutional Review Board of the University of Sao Paulo approved this study, and, after having been given a complete description of the study, all participants gave written informed consent. Materials
Diagnostic assessments were conducted using the SCID/P (8). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was administered to assess the severity of obsessive-compulsive symptoms (9). For the diagnosis of kleptomania, trichotillomania, pathological gambling, onychophagia and skin picking, specific modules were administered (10). Chronic motor and vocal tics were assessed using the Yale Global Tic Severity Scale (11). The specific module of the Kiddie Schedule for Affective Disorders and Schizophrenia, epidemiological edition (12) was applied to identify attention deficit hyperactivity disorder. Clinical information was obtained through the use of a retrospective mood chart (13), together with data from psychiatric interviews and medical records. Patients requiring antidepressant medication for at least 3 days per week in the 2 weeks preceding a manic episode, as defined by Stoll and colleagues (14), were considered to have treatmentemergent manic symptoms. Age at onset of BD was defined as the age at which the patient first met the DSM-IV criteria for a major mood episode, and age at onset of OCD was defined as the age at which the first obsessive or compulsive symptoms appeared. In accordance with the criteria adopted by Ros´arioCampos and colleagues (15), onset of OCD before the age of 10 years was classified as early-onset OCD. An episode was considered to be chronic if all criteria for a major mood episode were met continuously for at least 2 years. When symptoms of an episode continued, but all criteria for BD were no longer met, the patient was classified as having residual symptoms.
Bipolar disorder and obsessive-compulsive disorder Statistical analysis
All statistical analyses were conducted using the Statistical Package for the Social Sciences, version 14 (SPSS Inc., Chicago, IL), and two-tailed tests. The level of statistical significance was set at p < .05. We used a chi-squared test for categorical variables and the Student’s t-test for continuous variables. All of the continuous variables showed normal distribution. Results Sociodemographic data
There was no significant difference between the two groups in terms of marital status or employment (p > .05 for both). The proportions of single patients, patients who were married/living with a steady partner and divorced/separated patients were 40, 40 and 20%, respectively, for the BD+OCD group, compared with 26.7, 26.7 and 46.7%, respectively, for the BD/no-OCD group. In the BD+OCD group, 13% of the patients were unemployed, as were 26.7% of those in the BD/no-OCD group, although the difference between the two groups did not reach statistical significance for this variable. Clinical characteristics
Clinical characteristics of both patient groups are shown in Table 1. Mean Yale-Brown ObsessiveCompulsive Scale (Y-BOCS) score in the BD+OCD group was 26.1 ± 6.9. All patients in the BD+OCD group and 13 patients in the BD/no-OCD group were receiving drug treatment. There were 28 patients using mood stabilizers (15 in the BD+OCD group; 13 in the BD/no-OCD group), 14 using antipsychotics (9 in the BD+OCD group; 5 in the
BD/no-OCD group) and 12 using antidepressants (8 in the BD+OCD group; 4 in the BD/no-OCD group). The age at onset of BD was numerically lower in the BD+OCD group, although the difference between the two groups did not reach statistical significance. Of the 15 patients in the BD+OCD group, 9 (60%) had early-onset OCD (age at onset, .05). Excluding OCD, the number of Axis I comorbidities per patient was significantly higher in the BD+OCD group than the BD/no-OCD group (p = .009), with all the patients in this group having one or more comorbidity. This difference remained significant after the exclusion of tic disorders and impulse control disorders (p = .05). More than 95% of the patients in the BD+OCD group had at least two comorbidities other than OCD (Table 4). Discussion
In comparison with those in the BD/no-OCD group, the patients in the BD+OCD group had a greater number of previous depressive episodes, chronic episodes and residual symptoms, as well as higher rates of treatment-emergent affective switch. In addition, patients in the BD+OCD group had more coexisting psychiatric disorders, 93.3% having another anxiety disorder and 60% having impulse control disorders. Taken together, these findings suggest that, in comparison with their non-OCD counterparts, bipolar patients with OCD comorbidity suffer from a more severe form of disorder, as also suggested by Hantouche and colleagues (16). The emergence of antidepressant-associated mania has been previously documented in patients with OCD (17,18). In addition, Perugi and colleagues (17) showed that patients with BD and OCD have a greater number of concurrent major depressive episodes and treatment-emergent affective switches than do OCD patients without comorbid BD. Despite the early appearance of OCD symptoms, most of our patients sought treatment for BD symptoms, highlighting the importance of inquiring about obsessions and compulsions when evaluating BD patients, as recommended by Chen and Dilsaver (1). The inverse is also true for patients with OCD, because three patients in this cohort sought treatment for obsessivecompulsive symptoms and were unaware of having BD. In addition to the mood stabilizer resistance previously documented (19), comorbid OCD can render patients with BD more prone to treatmentemergent mania. 84
In our sample, the age at onset of BD did not differ between the two groups, despite the fact that the age at onset of BD was numerically lower in the BD+OCD group. Also, in our BD+OCD group, we found the onset of OCD to be much earlier than that of BD. This is in accordance with the findings of two previous studies (16,20) showing that the manifestation of obsessive-compulsive symptoms occurs early (before age 16) in OCD patients with comorbid BDs. Chen and Dilsaver (1) hypothesised that concurrence and same age at onset of BD and OCD can be interpreted as these two disorders having the same underlying diathesis. In our study, age at onset of BD was defined as the age at which the patient first met the DSM-IV criteria for a major mood episode, whereas age at onset of OCD was defined as the age at which the first obsessive or compulsive symptoms appeared. OCD research provides evidence for the existence of an early-onset subtype distinct from the other forms of the disorder, and our data also suggest that BD is associated with the early-onset OCD subtype (21,22). Although further studies are needed to confirm this finding, it might have some etiologic implications, as suggested by Chen and Dilsaver (1,21,22). Although 40% of the patients in our BD+OCD group reported one or more prior suicide attempts, this was not significantly different from the BD/noOCD group (33.3%). This is in accordance with Centorrino and colleagues’ finding of no significant differences in suicide attempts between BD patients with comorbid OCD and those with BD only (6). However, in this study, this result may reflect a possible type II error because of the small size of our sample. In contrast, Kr¨uger and colleagues (5) reported a higher incidence of prior suicide attempts in a group of male BD type II patients with OCD (n = 10) compared to BD patients without OCD, and all of the patients evaluated had been diagnosed with comorbid dysthymia, a condition that might explain the elevated suicide attempt rates. Chen and Dilsaver (1) also reported elevated suicidality in patients with OCD-BD comorbidity, although they explained this as being a function of the higher number of patients with comorbid panic disorder in their sample. Suicide attempt rates in OCD patients have been reported to be around 10–27% (23,24), and anxiety disorders are known independent risk factors for suicide attempts (25,26). Therefore, the elevated suicide rates observed in the BD+OCD patients may be attributable to OCD and other concurrent anxiety disorders. In this study, 93% of the patients in the BD+OCD group had another comorbid anxiety disorder; panic disorder, specific phobias and social phobia being the most prevalent. Chen and Dilsaver (1) reported
Bipolar disorder and obsessive-compulsive disorder a similar finding: increased rates of comorbid panic disorder in subjects with OCD-BD comorbidity. Masi and colleagues (20) found that the rate of panic disorder was higher among youths with OCD-BD comorbidity than among those with BD and no OCD. Finally, Dilsaver and colleagues (3) examined the question of ‘cumulative anxiety disorder comorbidity’ in juvenile patients with OCD-BD comorbidity and found that comorbid OCD resulted in a 10-fold increase in the odds of having panic disorder, whereas having OCD and panic disorder was associated with social phobia. Our finding of the cumulative presence of anxiety disorders in the BD+OCD group also supports the notion that the presence of one comorbid anxiety disorder can increase the chances of having another, as suggested by Dilsaver and colleagues (3). To the best of our knowledge, this is the first study to use specific modules to investigate impulse control disorders in BD patients with OCD. Of the 15 patients in the BD+OCD group, 9 (60%) had an impulse control disorder, compared with only 2 (13%) of those in the BD/no-OCD group. Although it is well established that anxiety and impulsivity are common characteristics of BD, the interplay between the two in BD is a topic that has rarely been investigated. One recent study (27) showed that BD patients with a comorbid anxiety disorder displayed significantly higher levels of impulsivity (as assessed using the Barratt Impulsiveness Scale) than did those without an anxiety disorder. Hantouche and colleagues (16) stated that a higher prevalence of concurrent disorders (panic disorder, phobias, anger attacks, impulsive disorders and eating disorders) is presumptive of bipolar OCD. However, the DSM-IV impulse control disorders comprise heterogeneous disorders, including different subgroups with some common features among them. For instance, skin picking, onychophagia and trichotillomania, along with tic disorders and body dysmorphic disorder, are now conceptualised as obsessive-compulsive spectrum disorders, based on common psychopathological features and genetic background (21,28). Such disorders were more common in the BD+OCD group in our sample; however, based on the ‘obsessivecompulsive spectrum disorders’ conceptualisation, one might also argue that it is expected to see more of these disorders in any population of patients with OCD. Additional research is needed to examine the complex interplay between impulse controls disorders, OCD and BD. By including only female patients, we were able to control for possible confounding factors related to gender. However, the small sample size constitutes a significant limitation of our study. Although the
exclusion of males made our sample more homogeneous, it also reduced the external validity of our findings. Therefore, future studies on this theme should include larger patient samples, composed of both genders, to validate the findings described here. A major strength of this work is that our data were collected using structured interviews and wellestablished assessment scales. Our findings complement and enhance those of previous studies, showing that OCD-BD comorbidity is linked with greater illness severity. Patients with OCD-BD comorbidity present a higher number of depressive episodes, have more residual symptoms and are at a greater risk of treatment-emergent mania. These findings could have significant clinical implications. For instance, in view of research favouring atypical antipsychotic augmentation for OCD that is refractory to selective serotonin uptake inhibitors (29,30), the choice of atypical antipsychotics should be considered in patients with OCD-BD comorbidity, because it might help prevent antidepressant-associated manic switch (16,31) and could improve the symptoms related to both disorders. Clinicians should also be aware of the higher rates of anxiety disorders and impulse control disorders commonly seen in this subgroup of patients and should establish comprehensive therapeutic strategies for treating these patients. Finally, although the data available are insufficient to allow us to define OCD-BD comorbidity as a distinct entity, future research examining the familial-genetic and neurobiological aspects of this comorbidity will further the understanding of its exact nature. Acknowledgements This research was supported in part by a generous donation from the Thompson Motta Family. Dr Lafer has received speaker’s honoraria from AstraZeneca in 2007. Dr Monkul is an employee of Eli Lilly Brazil. Address of the department to which the work should be attributed is Department of Psychiatry, University of S˜ao Paulo School of Medicine, S˜ao Paulo, Brazil. The authors do not have any affiliation with or financial interest in any organisation that might pose a conflict of interest.
References 1. Chen YW, Dilsaver SC. Comorbidity for obsessivecompulsive disorder in bipolar and unipolar disorders. Psychiatry Res 1995;59:57–64. 2. Angst J, Gamma A, Endrass J et al. Obsessivecompulsive syndromes and disorders: significance of comorbidity with bipolar disorder and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci 2005;255:65–71. 3. Dilsaver SC, Akiskal HS, Akiskal KK, Benazzi F. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality. J Affect Disord 2006;96:249–258.
85
Issler et al. 4. Grabe HJ, Meyer C, Hapke U et al. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessivecompulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci 2001;251:130–135. ¨ 5. Kruger S, Braunig P, Cooke RG. Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord 2000;2:71–74. 6. Centorrino F, Hennen J, Mallya G, Egli S, Clark T, Baldessarini RJ. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both. Hum Psychopharmacol Clin Exp 2006;21:189–193. 7. Issler CK, Amaral JAMS, Tamada RS et al. Clinical expression of obsessive-compulsive disorder in women with bipolar disorder. Rev Bras Psiquiatr 2005;27:139–142. 8. First MB, Spitzer RL, Gibson M et al. Structured clinical interview for DSM-IV Axis I disorders – patient edition (version 2.0, 8/98 revision). New York, Biometrics Research Department; 1997. 9. Goodman WK, Price LH, Rasmussen SA et al. The YaleBrown Obsessive Compulsive Scale: development, use and reliability. Arch Gen Psychiatry 1989;46:1006–1011. 10. First MB. Structured clinical interview for DSM-IV-TR Impulse Control Disorders Not Elsewhere Classified (SCIDTCIm). Biometrics Research Department; New York State Psychiatric Institute; September 2004. 11. Leckman JF, Riddle MA, Hardin MT et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566–573. 12. Orvaschel H, Pu˙Ig-Ant˙Ich J. Kiddie-SADS-E: Schedule for affective disorder and Schizophrenia for school-age children – epidemiologic version (4th version). Ft. Lauderdale, Fl. Nova University, Center for Psychological Study; 1987. 13. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996;(2 Suppl. 1):32S–47S. 14. Stoll AL, Mayer PV, Kolbrener M et al. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994;151: 1642–1645. 15. Rosar˙Io-Campos MC, Leckman JF, Mercadante MT et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry 2001;158:1899–1903. 16. Hantouche EG, Angst J, Demonfaucon C, Perugi G, Lancrenon S, Akiskal HS. Cyclothymic OCD: a distinct form? J Affect Disord 2003;75:1–10. 17. Perug˙I G, Ton˙I C, Frare F, Trav˙Ierso MC, Hantouche MC, Ak˙Iskal HS. Obsessive-compulsive-bipolar comorbid-
86
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
ity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry 2002;63:1129–1134. Berk M, Koopowitz LE, Szabo CP. Antidepressantinduced mania in OCD. Eur Neuropsychopharmacol 1996; 6:9–11. Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen G. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004;65:1106–1113. Mas˙I G, Perug˙I G, Ton˙I C et al. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord 2004;78:175–183. M˙Iguel EC, Leckman JF, Rauch S et al. Obsessivecompulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005;10:258–275. ´ de Mathis MA, Diniz JB, do Rosario MC et al. What is the optimal way to subdivide obsessive-compulsive disorder? CNS Spectr 2006;11:762–768, 771–774, 776–779. Torres AR, de Abreu Ramos-Cerqueira AT, Torresan RC, de Souza Dom˙Ingues M, Hercos AC, ˜ AB. Prevalence and associated factors for suiciGu˙Imaraes dal ideation and behaviors in obsessive-compulsive disorder. CNS Spectr 2007;12:771–778. Kamath P, Reddy YC, Kandavel T. Suicidal behavior in obsessive-compulsive disorder. J Clin Psychiatry 2007;68:1741–1750. Norton PJ, Temple SR, Pett˙It JW. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression? J Behav Ther Exp Psychiatry 2008;39:515–525. Bolton JM, Cox BJ, Af˙If˙I TO, Enns MW, B˙Ienvenu OJ, Sareen J. Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow-up study. Depress Anxiety 2008;25:477–481. Taylor CT, H˙Irshfeld-Becker DR, Ostacher MJ et al. Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord 2008;22:868–876. B˙Ienvenu OJ, Samuels JF, R˙Iddle MA et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000;48:287–293. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995;56:423–429. Koran LM, Ringold AL, Elliott MA. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2000;61:514–517. Raja M, Azzon˙I A. Clinical management of obsessivecompulsive-bipolar comorbidity: a case series. Bipolar Disord 2004;6:264–270.
